194 related articles for article (PubMed ID: 35013765)
1. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
[TBL] [Abstract][Full Text] [Related]
3. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
[TBL] [Abstract][Full Text] [Related]
4. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
[TBL] [Abstract][Full Text] [Related]
5. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).
Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
[TBL] [Abstract][Full Text] [Related]
7. Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy.
Furumoto H; Okada R; Kato T; Wakiyama H; Inagaki F; Fukushima H; Okuyama S; Furusawa A; Choyke PL; Kobayashi H
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011036
[TBL] [Abstract][Full Text] [Related]
8. Near-infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab-IR700.
Takao S; Fukushima H; King AP; Kato T; Furusawa A; Okuyama S; Kano M; Choyke PL; Escorcia FE; Kobayashi H
Cancer Sci; 2023 Dec; 114(12):4654-4663. PubMed ID: 37817415
[TBL] [Abstract][Full Text] [Related]
9. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.
Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK
Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755
[TBL] [Abstract][Full Text] [Related]
10. Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes.
Hirata H; Kuwatani M; Nakajima K; Kodama Y; Yoshikawa Y; Ogawa M; Sakamoto N
Cancer Sci; 2021 Feb; 112(2):828-838. PubMed ID: 33345417
[TBL] [Abstract][Full Text] [Related]
11. Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer.
Nakamura Y; Ohler ZW; Householder D; Nagaya T; Sato K; Okuyama S; Ogata F; Daar D; Hoa T; Choyke PL; Kobayashi H
Mol Cancer Ther; 2017 Feb; 16(2):408-414. PubMed ID: 28151706
[TBL] [Abstract][Full Text] [Related]
12. Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.
Ito K; Mitsunaga M; Nishimura T; Saruta M; Iwamoto T; Kobayashi H; Tajiri H
Bioconjug Chem; 2017 May; 28(5):1458-1469. PubMed ID: 28402624
[TBL] [Abstract][Full Text] [Related]
13. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer.
Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M
Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134
[TBL] [Abstract][Full Text] [Related]
14. Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.
Inagaki FF; Wakiyama H; Furusawa A; Okada R; Kato T; Fujimura D; Okuyama S; Fukushima H; Takao S; Choyke PL; Kobayashi H
Biomed Pharmacother; 2023 Apr; 160():114390. PubMed ID: 36791566
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green.
Inagaki FF; Fujimura D; Furusawa A; Okada R; Wakiyama H; Kato T; Choyke PL; Kobayashi H
Mol Pharm; 2021 Mar; 18(3):1238-1246. PubMed ID: 33502869
[TBL] [Abstract][Full Text] [Related]
16. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy.
Mitsunaga M; Nakajima T; Sano K; Kramer-Marek G; Choyke PL; Kobayashi H
BMC Cancer; 2012 Aug; 12():345. PubMed ID: 22873679
[TBL] [Abstract][Full Text] [Related]
17. Near Infrared Photoimmunotherapy with Combined Exposure of External and Interstitial Light Sources.
Maruoka Y; Nagaya T; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
Mol Pharm; 2018 Sep; 15(9):3634-3641. PubMed ID: 29450993
[TBL] [Abstract][Full Text] [Related]
18. Selective Photokilling of Colorectal Tumors by Near-Infrared Photoimmunotherapy with a GPA33-Targeted Single-Chain Antibody Variable Fragment Conjugate.
Wei D; Tao Z; Shi Q; Wang L; Liu L; She T; Yi Q; Wen X; Liu L; Li S; Yang H; Jiang X
Mol Pharm; 2020 Jul; 17(7):2508-2517. PubMed ID: 32396000
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy.
Okada R; Maruoka Y; Furusawa A; Inagaki F; Nagaya T; Fujimura D; Choyke PL; Kobayashi H
Bioconjug Chem; 2019 Oct; 30(10):2624-2633. PubMed ID: 31498995
[TBL] [Abstract][Full Text] [Related]
20. Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.
Nagaya T; Gorka AP; Nani RR; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Schnermann MJ; Kobayashi H
Mol Cancer Ther; 2018 Mar; 17(3):661-670. PubMed ID: 29237807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
